THe Green Organic Dutchman - MMJ (Seite 127)
eröffnet am 14.03.18 16:54:47 von
neuester Beitrag 01.08.23 16:17:31 von
neuester Beitrag 01.08.23 16:17:31 von
Beiträge: 1.325
ID: 1.276.252
ID: 1.276.252
Aufrufe heute: 0
Gesamt: 122.382
Gesamt: 122.382
Aktive User: 0
ISIN: CA12464X1015 · WKN: A3D6NK
0,0185
EUR
-24,49 %
-0,0060 EUR
Letzter Kurs 22:16:04 Lang & Schwarz
Neuigkeiten
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 3,5800 | +922,86 | |
| 1,0400 | +48,57 | |
| 0,5400 | +38,46 | |
| 1,9900 | +32,67 | |
| 5,4000 | +27,06 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 14,510 | -32,32 | |
| 28,18 | -32,62 | |
| 3,6400 | -38,62 | |
| 0,5660 | -40,42 | |
| 84,75 | -74,50 |
Beitrag zu dieser Diskussion schreiben
Feedback
Korrekt ist 970.000 sqf = ca. 90.000 m2.
Antwort auf Beitrag Nr.: 57.290.635 von praesens am 15.03.18 17:39:29
Wenn ich z.B. 1o.ooo qm Weizenanbau ernte, habe ich gerade mal 300 - 400 kg Weizen geerntet.
116 Tonnen wie angegeben wird, das kann ich unmöglich glauben.
Blüten sind ja sehr schwer. Da brauchen die ja mindestens 100 Sattelschlepper.
Die Moral, nicht alles ist wahr.
Gewächshäuser 9290 qm, das sind kapp 100 x 100 m. (TGOD) 24.05.2018
Bei 10000 qm sollen jährlich 116 Tonnen Cannabisblüten getrocknet geerntet werden. 
Wenn ich z.B. 1o.ooo qm Weizenanbau ernte, habe ich gerade mal 300 - 400 kg Weizen geerntet.
116 Tonnen wie angegeben wird, das kann ich unmöglich glauben.
Blüten sind ja sehr schwer. Da brauchen die ja mindestens 100 Sattelschlepper.
Die Moral, nicht alles ist wahr.
Antwort auf Beitrag Nr.: 57.814.802 von Nico1977 am 23.05.18 13:57:08
the "Whole Foods" of the cannabis Industry
https://www.energyandcapital.com/articles/dont-underestimate… Trading Spotlight
https://globenewswire.com/news-release/2018/05/22/1510053/0/…
"The Green Organic Dutchman Announces Exclusive License for CBx Enterprises’ Cannabinoid Technologies
May 22, 2018 08:57 ET | Source: The Green Organic Dutchman Holdings Ltd.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES NEWS WIRE SERVICES
TORONTO, May 22, 2018 (GLOBE NEWSWIRE) -- The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) is pleased to announce that the Company has entered into an exclusive agreement with CBx Enterprises LLC for the licensing of the Evolab and CBx Sciences brands and proprietary technologies and formulations within Canada and other international jurisdictions outside of the USA.
Based in Colorado, the CBx team brings decades of experience developing and marketing a diverse array of unique, first-to-market medical and recreational cannabis products. The licensing arrangement will immediately expand TGOD’s product and technology portfolio, and position the Company for the successful development of new products as Canadian and global product requirements and standards rapidly evolve.
Evolab is a top cannabinoid vaporization brand that has gained significant market share through the creation of highly differentiated products in a very competitive and saturated market. Evolab’s proprietary technologies and industry-leading extraction efficiencies allow for the derivation of pharmaceutical-grade cannabinoid oils and strain-specific terpenes without the use of any harmful solvents or cutting-agents. These technologies and formulations lead to the creation of much cleaner and safer full-plant oils for vaporization without the introduction of chemicals commonly found in the e-vape industry.
CBx Sciences has an industry-leading team working tirelessly on the research and development of both new and novel cannabinoids as well as authentic premium quality consumer products. With a focus on identifying synergistic and complimentary botanical ingredients to activate and engage the endocannabinoid system, the research behind each advanced CBx formulation is unmatched in the industry. This focus on research as well as a deep understanding of the commercialization of cannabinoid-based products will allow for the development of product formulations that are tailored to each individual jurisdiction’s regulatory requirements for both non-psychoactive and psychoactive cannabinoids.
“TGOD is building an unrivaled global infrastructure for the development and distribution of cutting edge cannabinoid products,” said Nicole Smith, CEO, CBx Enterprises. “With their distinguished leadership team and recent successful execution of the largest cannabis IPO in history, there is no partner better positioned to rapidly extend the reach of our proven products and technology.”
“This licensing partnership for industry leading technologies and formulations will further allow TGOD to execute on its plans of offering novel and safer delivery methods of both non-psychoactive and psychoactive cannabinoids to patients and consumers around the globe,” said Rob Anderson, Co-Chairman and CEO of TGOD. “The team at CBx has vast experience in researching and commercializing new and novel consumer products and cannabinoids, and we are excited to be able to offer a platform to take their cutting-edge technologies and advanced formulations worldwide using TGOD’s premium organic ingredients under TGOD’s own brand names.”
..."
"The Green Organic Dutchman Announces Exclusive License for CBx Enterprises’ Cannabinoid Technologies
May 22, 2018 08:57 ET | Source: The Green Organic Dutchman Holdings Ltd.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES NEWS WIRE SERVICES
TORONTO, May 22, 2018 (GLOBE NEWSWIRE) -- The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) is pleased to announce that the Company has entered into an exclusive agreement with CBx Enterprises LLC for the licensing of the Evolab and CBx Sciences brands and proprietary technologies and formulations within Canada and other international jurisdictions outside of the USA.
Based in Colorado, the CBx team brings decades of experience developing and marketing a diverse array of unique, first-to-market medical and recreational cannabis products. The licensing arrangement will immediately expand TGOD’s product and technology portfolio, and position the Company for the successful development of new products as Canadian and global product requirements and standards rapidly evolve.
Evolab is a top cannabinoid vaporization brand that has gained significant market share through the creation of highly differentiated products in a very competitive and saturated market. Evolab’s proprietary technologies and industry-leading extraction efficiencies allow for the derivation of pharmaceutical-grade cannabinoid oils and strain-specific terpenes without the use of any harmful solvents or cutting-agents. These technologies and formulations lead to the creation of much cleaner and safer full-plant oils for vaporization without the introduction of chemicals commonly found in the e-vape industry.
CBx Sciences has an industry-leading team working tirelessly on the research and development of both new and novel cannabinoids as well as authentic premium quality consumer products. With a focus on identifying synergistic and complimentary botanical ingredients to activate and engage the endocannabinoid system, the research behind each advanced CBx formulation is unmatched in the industry. This focus on research as well as a deep understanding of the commercialization of cannabinoid-based products will allow for the development of product formulations that are tailored to each individual jurisdiction’s regulatory requirements for both non-psychoactive and psychoactive cannabinoids.
“TGOD is building an unrivaled global infrastructure for the development and distribution of cutting edge cannabinoid products,” said Nicole Smith, CEO, CBx Enterprises. “With their distinguished leadership team and recent successful execution of the largest cannabis IPO in history, there is no partner better positioned to rapidly extend the reach of our proven products and technology.”
“This licensing partnership for industry leading technologies and formulations will further allow TGOD to execute on its plans of offering novel and safer delivery methods of both non-psychoactive and psychoactive cannabinoids to patients and consumers around the globe,” said Rob Anderson, Co-Chairman and CEO of TGOD. “The team at CBx has vast experience in researching and commercializing new and novel consumer products and cannabinoids, and we are excited to be able to offer a platform to take their cutting-edge technologies and advanced formulations worldwide using TGOD’s premium organic ingredients under TGOD’s own brand names.”
..."
heute ist ein guter Tag bei den meisten Cannabis-Werten. Handelsvolumen bei TGOD aktuell 4,3 Mio.
Hallo tgod Gemeinde, bin seit heute mit ner kleinen posi dabei! Bei niedrigeren Kurse werde ich immer wieder mal nachkaufen.😁
Durchsuchen
